EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Micropillar array-based microfluidic device for electrochemical monitoring of cell culture health

Masoud Khazaei, Jann Harberts, Azadeh Nilghaz, Michael Shola David, Kenneth Galbraith, Muamer Dervisevic, Victor J Cadarso, Nicolas H Voelcker

Biosensors and Bioelectronics · 2025-09 · 283 · 117534

DOI: 10.1016/j.bios.2025.117534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-09. Verfasst von Masoud Khazaei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia; Melbourne Centre for Nanofabrication, Victorian…. Hauptthemen laut MEDLINE: Biosensing Techniques, Glucose, Electrochemical Techniques, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alexander von Humboldt-Stiftung, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose levels serve as a fundamental indicator of cell health, reflecting crucial aspects of cellular metabolism and energy production. While effective, traditional methods such as spectrophotometry and chromatography have limitations, such as labour-intensive sample collection, reliance on bulky equipment, extensive sample preparation, and prolonged experimental durations. To address these issues, we introduce a micropillar-based microfluidic electrochemical device (MED) for real-time monitoring of glucose levels in diverse cell culture systems, including human induced pluripotent stem cells (hiPSCs) and murine fibroblast cells (GP + E86). This biosensor demonstrates a linear range of 0.025-1.50 mM and a high sensitivity of 4.71 ± 0.13 μA. mM-1, and a low limit of detection of 19.10 ± 0.50 μM. The MED not only delivered fast glucose measurements with accuracy and reliability comparable to ultra-high-performance liquid chromatography (UHPLC) but was also specifically evaluated on GP + E86 murine fibroblast cells at varying seeding densities (1:5 and 1:10 ratios), across different culturing times to accurately monitor dynamic metabolic shifts associated with various growth phases. Furthermore, the MED effectively detected significant changes in glucose consumption in hiPSCs cell cultures contaminated with Escherichia coli (E. coli), highlighting its potential for early contamination detection. Integrating non-invasive, continuous monitoring platforms enhances the reliability of experimental outcomes by enabling cell health monitoring without disrupting the cell culture process. This approach enables real-time monitoring of cell cultures ensuring accurate detection of metabolic changes and early detection of media contamination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesGlucoseElectrochemical TechniquesLab-On-A-Chip DevicesMicrofluidic Analytical TechniquesAnimalsMiceHumansFibroblastsInduced Pluripotent Stem CellsCell Culture TechniquesEquipment DesignEscherichia coliLimit of Detection

Stichwörter der Autor:innen

Cell culture healthElectrochemical biosensorGlucose monitoringMicrofluidic deviceMicropillar array

Substanzen

Glucose

Autor:innen und Institutionen

  • Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia; Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, Clayton, Victor…
  • Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia; Institute for Frontier Materials, Deakin University, Geelong, Victoria, 3216, Australia.
  • Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, Clayton, Victoria, 3168, Australia; Materials Science and Engineering, Monash University, Clayton, Victoria, 3168, Au…
  • Invetech Pty Ltd, Cell Therapy Department, Mount Waverly, 3149, Victoria, Australia.
  • Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, Clayton, Victoria, 3168, Australia; Department of Mechanical & Aerospace Engineering, Monash University, Clayton, VIC…

Förderung

  • Alexander von Humboldt-Stiftung
  • Australian Research Council

Zitieren

APA

Khazaei, M., Harberts, J., Nilghaz, A., David, M. S., Galbraith, K., Dervisevic, M., Cadarso, V. J., & Voelcker, N. H. (2025). Micropillar array-based microfluidic device for electrochemical monitoring of cell culture health. Biosensors and Bioelectronics, 283, 117534. https://doi.org/10.1016/j.bios.2025.117534

Vancouver

Khazaei M, Harberts J, Nilghaz A, David MS, Galbraith K, Dervisevic M, et al. Micropillar array-based microfluidic device for electrochemical monitoring of cell culture health. Biosensors and Bioelectronics. 2025;283:117534. doi:10.1016/j.bios.2025.117534

BibTeX
@article{Khazaei2025,
  author = {Khazaei, Masoud and Harberts, Jann and Nilghaz, Azadeh and David, Michael Shola and Galbraith, Kenneth and Dervisevic, Muamer and Cadarso, Victor J and Voelcker, Nicolas H},
  title = {Micropillar array-based microfluidic device for electrochemical monitoring of cell culture health},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  volume = {283},
  pages = {117534},
  doi = {10.1016/j.bios.2025.117534}
}
Kostenlos starten →